biopharmaceuticals

Banner image with text: 'Stay informed with the latest IP news' and the following words listed: Insights, Interviews, Webinars.

Affibody molecule: A molecule that can detect breast cancer

By AWA | Posted on October 31, 2018

Every month is breast cancer awareness month for Swedish Biopharmaceutical R&D company Affibody, which has developed unique molecular technologies to localise cancerous tumours and individualise drug treatment for patients Director of Alliance and IP Management at Affibody Caroline Ekblad has been with the Solna based company since 2007. She started out working with research, but...

Read more : Affibody molecule: A molecule that can detect breast cancer

Filed under: Interviews

Tags: Affibody, Albumod, biopharmaceuticals, breast cancer, cancer, diagnostics, Intellectual Property, molecules, patents

Recent contributors

Thomas Ewing, Senior Counsel and IP Strategist, Gothenburg, Sweden

Thomas Ewing

Senior Counsel, IP Strategist

Yongjia Zhou, Associate and China Patent Attorney, Beijing, China

Yongjia Zhou

Associate, China Patent Attorney

Ai-Leen Lim, Partner and Attorney at Law, Hong Kong SAR

Ai-Leen Lim

Partner, Attorney at Law, Group Vice President

Joanna Lu, Senior Associate and Attorney at Law, Beijing, China

Joanna Lu

Senior Associate, Attorney at Law

Anders Heebøll-Nielsen, Partner and European Patent Attorney, Copenhagen, Denmark

Anders Heebøll-Nielsen

Partner, European Patent Attorney, Certified Danish Patent Agent

Ashley Zhao, Partner and Attorney at Law, Beijing, China

Ashley Zhao

Partner, Attorney at Law, Business Area Manager